Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer’s disease treatment
Authors:
- 1 December 2016
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 46, 177-190
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21171070, 21371075)
- Natural Science Foundation of Guangdong Province (2014A030311025, S2013010011660)
- Planned Item of Science and Technology of Guangdong Province (2016A020217011)
This publication has 49 references indexed in Scilit:
- Single Molecule Characterization of the Interactions between Amyloid-β Peptides and the Membranes of Hippocampal CellsJournal of the American Chemical Society, 2013
- Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42PeptideJournal of the American Chemical Society, 2012
- Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In VivoPLOS ONE, 2012
- Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid BilayersACS Nano, 2012
- Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issuesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- A Biocompatible Oxidation-Triggered Carrier Polymer with Potential in TherapeuticsJournal of the American Chemical Society, 2010
- Increased delivery of TAT across an endothelial monolayer following ischemic injuryNeuroscience Letters, 2010
- Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in AnimalsSmall, 2010
- Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic statesProceedings of the National Academy of Sciences, 2010
- Pathways towards and away from Alzheimer's diseaseNature, 2004